Access barriers to epinephrine autoinjectors for the treatment of anaphylaxis: A survey of practitioners
Punita Ponda
1
,
Anne F Russell
2
,
Joyce E. Yu
3
,
Michael H Land
4
,
Maria G Crain
5
,
Kiran Patel
6
,
Jodi A. Shroba
7
,
Panida Sriaroon
8
1
Division of Allergy and Immunology, Department of Pediatrics, Cohen Children’s Medical Center of New York, Donald Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY
|
4
Allergy Department, Southern California Permanente Medical Group, San Diego, Calif
|
6
Division of Pulmonology, Allergy, Cystic Fibrosis, and Sleep Medicine, Department of Pediatrics, Children’s Healthcare of Atlanta, Atlanta, Ga
|
7
Division of Allergy and Immunology. Children’s Mercy Hospital, Kansas City, Mo
|
Publication type: Journal Article
Publication date: 2021-10-01
scimago Q1
wos Q1
SJR: 1.834
CiteScore: 11.0
Impact factor: 6.6
ISSN: 22132198, 22132201
PubMed ID:
34126272
Immunology and Allergy
Abstract
Epinephrine is the first-line treatment for systemic allergic reactions including anaphylaxis and commonly prescribed for self-administration as an epinephrine autoinjector (EAI).1 More EAI prescriptions have been written during the past decade, with an annualized growth of 8% between 2004 and 2010.2 The 2016 U.S. congressional hearings reported considerable EAI price hikes coupled with increased demand.3 Although the U.S. Food and Drug Administration first noted EAI shortages in May 2018, shortages are ongoing, directly impacting patient care.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
|
|
|
Current Allergy and Asthma Reports
1 publication, 14.29%
|
|
|
Journal of Allergy and Clinical Immunology: In Practice
1 publication, 14.29%
|
|
|
Journal of food allergy
1 publication, 14.29%
|
|
|
Annals of Allergy, Asthma and Immunology
1 publication, 14.29%
|
|
|
Clinical and Translational Allergy
1 publication, 14.29%
|
|
|
Allergy: European Journal of Allergy and Clinical Immunology
1 publication, 14.29%
|
|
|
1
|
Publishers
|
1
2
3
|
|
|
Elsevier
3 publications, 42.86%
|
|
|
Wiley
2 publications, 28.57%
|
|
|
Springer Nature
1 publication, 14.29%
|
|
|
1
2
3
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
7
Total citations:
7
Citations from 2024:
3
(42.86%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Ponda P. et al. Access barriers to epinephrine autoinjectors for the treatment of anaphylaxis: A survey of practitioners // Journal of Allergy and Clinical Immunology: In Practice. 2021. Vol. 9. No. 10. pp. 3814-38150000.
GOST all authors (up to 50)
Copy
Ponda P., Russell A. F., Yu J. E., Land M. H., Crain M. G., Patel K., Shroba J. A., Sriaroon P. Access barriers to epinephrine autoinjectors for the treatment of anaphylaxis: A survey of practitioners // Journal of Allergy and Clinical Immunology: In Practice. 2021. Vol. 9. No. 10. pp. 3814-38150000.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.jaip.2021.05.028
UR - https://doi.org/10.1016/j.jaip.2021.05.028
TI - Access barriers to epinephrine autoinjectors for the treatment of anaphylaxis: A survey of practitioners
T2 - Journal of Allergy and Clinical Immunology: In Practice
AU - Ponda, Punita
AU - Russell, Anne F
AU - Yu, Joyce E.
AU - Land, Michael H
AU - Crain, Maria G
AU - Patel, Kiran
AU - Shroba, Jodi A.
AU - Sriaroon, Panida
PY - 2021
DA - 2021/10/01
PB - Elsevier
SP - 3814-38150000
IS - 10
VL - 9
PMID - 34126272
SN - 2213-2198
SN - 2213-2201
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2021_Ponda,
author = {Punita Ponda and Anne F Russell and Joyce E. Yu and Michael H Land and Maria G Crain and Kiran Patel and Jodi A. Shroba and Panida Sriaroon},
title = {Access barriers to epinephrine autoinjectors for the treatment of anaphylaxis: A survey of practitioners},
journal = {Journal of Allergy and Clinical Immunology: In Practice},
year = {2021},
volume = {9},
publisher = {Elsevier},
month = {oct},
url = {https://doi.org/10.1016/j.jaip.2021.05.028},
number = {10},
pages = {3814--38150000},
doi = {10.1016/j.jaip.2021.05.028}
}
Cite this
MLA
Copy
Ponda, Punita, et al. “Access barriers to epinephrine autoinjectors for the treatment of anaphylaxis: A survey of practitioners.” Journal of Allergy and Clinical Immunology: In Practice, vol. 9, no. 10, Oct. 2021, pp. 3814-38150000. https://doi.org/10.1016/j.jaip.2021.05.028.